Victory Square Technologies Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VSQTF research report →
Price Chart
About the company
Victory Square Technologies Inc. operates as an investment entity, providing both venture capital and private equity. It specializes in fostering the growth of early-stage startups through incubation, direct investment, and strategic acquisitions.
- CEO
- Shafin Diamond Tejani
- IPO
- 2016
- Employees
- 2
- HQ
- Vancouver, BC, CA
Get TickerSpark's AI analysis on VSQTF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $45.75M
- P/E
- 12.05
- PEG
- -0.00
- P/S
- 1.12
- P/B
- 1.39
- EV/EBITDA
- 9.36
- Div Yield
- 0.00%
- Gross Margin
- 20.86%
- Op Margin
- 6.26%
- Net Margin
- 9.10%
- ROE
- 18.75%
- ROIC
- 6.37%
Latest fiscal year · YoY change
- Revenue
- $35.39M+111.7%
- Gross Profit
- $9.00M+41.4%
- Op Income
- $682.59K
- Net Income
- $2.04M+65.1%
- EPS
- $0.02+100.0%
- OCF Growth
- -529.2%
- FCF Growth
- -177.7%
- 52W High
- $0.72
- 52W Low
- $0.30
- 50D MA
- $0.48
- 200D MA
- $0.48
- Beta
- 1.11
- RSI (14)
- 40
- Avg Volume
- 62.48K
No earnings-call transcripts are available for VSQTF yet.
- Free Float
- 99.5%
- Shares Outstanding
- 104.22M
- Float Shares
- 103.69M
Our VSQTF coverage
Recent articles, reports, and earnings notes.
No research on VSQTF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate VSQTF report →Hydreight to Participate in Canaccord Genuity's 46th Annual Growth Conference in Boston
prnewswire.com · Aug 6
Victory Square Provides Update on Hydreight and Healthcare Investments Following FDA Advisory Committee Recommendations on Peptide-Related Bulk Drug Substances
prnewswire.com · Jul 29
Hydreight Provides Business Update on its Peptide Healthcare Platform Following Recent FDA Advisory Committee Recommendations
prnewswire.com · Jul 29
Victory Square Reports Q1 2026 Financial Results and Provides Portfolio Update
gurufocus.com · Jun 2
Victory Square Reports Q1 2026 Financial Results and Provides Portfolio Update
prnewswire.com · Jun 2
Hydreight Delivers Record First Quarter 2026 Revenue of $24.9 Million with 449% Revenue Growth, $3.3 Million in Adjusted EBITDA² and $32.0 Million in Working Capital
gurufocus.com · Jun 1
Hydreight Delivers Record First Quarter 2026 Revenue of $24.9 Million with 449% Revenue Growth, $3.3 Million in Adjusted EBITDA² and $32.0 Million in Working Capital
prnewswire.com · Jun 1
Hydreight Technologies Announces Timing of Q1 2026 Financial Results and Investor Webcast
prnewswire.com · May 26
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.